Table 1.
Clinical characteristics of breast cancer patients (N=118) undergoing volume replacement with diced acellular dermal matrix
| Characteristics | N (%) |
|---|---|
| Age (years) | |
| 20–50 | 49 (44.9%) |
| > 50 | 69 (55.1%) |
| T stage | |
| Tis | 17 (14.4%) |
| T1 | 63 (53.4%) |
| T2 | 14 (11.9%) |
| ypTis | 1 (0.8%) |
| ypT0 | 4 (3.4%) |
| ypT1 | 7 (5.9%) |
| ypT2 | 9 (7.6%) |
| ypT3 | 3 (2.5%) |
| Pathology | |
| DCIS | 17 (14.4%) |
| IDC | 88 (74.6%) |
| ILC | 2 (1.7%) |
| Others | 11 (9.3%) |
| Location of cancer in breast | |
| Upper | 88 (74.6%) |
| Central | 10 (8.5%) |
| Lower | 20 (16.9%) |
| Resection volume (cm3) | |
| 0–50 | 62 (52.5%) |
| 50–100 | 32 (27.1%) |
| > 100 | 24 (20.3%) |
DCIS ductal carcinoma in situ, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma